SCHEMBL2158462

SCHEMBL2158462

CC(=O)ONC1c2cccc(-c3cnc4ccccc4c3)c2-n2cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.42
CSNK1G2 P78368 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
MAP4K5 Q9Y4K4 1/20 0.42
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
NTSR1 P30989 2/20 0.37
HSP90AA1 P07900 3/20 0.36
POLQ O75417 1/20 0.35
AVPR2 P30518 1/20 0.35
AVPR1A P37288 1/20 0.35
PIK3CA P42336 3/20 0.35
MTOR P42345 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
BRD4 O60885 2/20 0.35
CREBBP Q92793 2/20 0.35
SLC22A12 Q96S37 1/20 0.34
FASN P49327 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2158454 0.81 MAP4K4 (0.45) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL1551599 0.77 BIRC5 (0.41) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL2158477 0.75 HSP90AB1 (0.49) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL13575004 0.73 HSP90AA1 (0.34) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL1551276 0.68 CA12 (0.45) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL1550962 0.66 BIRC5 (0.41) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL1550960 0.66 BIRC5 (0.41) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
Hydrochloric Acid SCHEMBL2158654 0.66 BIRC5 (0.40) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
Hydrochloric Acid SCHEMBL2158655 0.66 BIRC5 (0.40) MAP4K4CSNK1G2CLK4MKNK2MAP4K5
SCHEMBL7189579 0.63 POLB (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178687-B2 Derivatives of pyrroloindole which are inhibitors of Hsp90, compositions containing same, and use thereof SANOFI-AVENTIS (FR) 2012-05-15 US disclosed
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF SANOFI-AVENTIS (FR) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 MAP4K4 3195/4885CSNK1G2 223/4885CLK4 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.